CELMoDs – The Future of Multiple Myeloma Treatment..

stvorio je novi članak

35 u

CELMoDs – The Future of Multiple Myeloma Treatment and a Successor to REVLIMID | #healthcare

CELMoDs – The Future of Multiple Myeloma Treatment and a Successor to REVLIMID

The field of multiple myeloma treatment is advancing rapidly, with CELMoDs (Cereblon E3 Ligase Modulators) emerging as a powerful alternative to Revlimid.

Kao Ne sviđa mi se

Komentar

Udio